Diagnostic and Treatment Challenges in Cerebral Tuberculoma in a Patient with Morbid Obesity
BACKGROUND Tuberculosis is prevalent, especially in low-income countries. The most devastating manifestation of tuberculosis is central nervous system (CNS) involvement, albeit rare. CASE REPORT We report a rare case of a 26-year-old woman with morbid obesity and hepatitis C who had cerebral tuberculoma and was treated with an extended duration of anti-tuberculosis multi-drug therapy. This patient was initially diagnosed with disseminated tuberculosis of the lungs, liver, and peritoneum. After 4 months of anti-tuberculosis treatment, she developed new right temporal hemianopia and new cerebral tuberculoma, which was identified on repeated magnetic resonance imaging (MRI) and was attributed to tuberculosis-immune reconstitution inflammatory syndrome. The anti-tuberculosis treatment was continued; however, she gained large amounts of weight, which resulted in the failure of the anti-tuberculosis treatment of the cerebral tuberculoma. We decided to adjust the anti-tuberculosis drug dosage using her total body weight, and she responded well, with a decrease in size of the cerebral tuberculoma. The anti-tuberculosis treatment was subsequently stopped after 3 years because of clinical and imaging improvement. CONCLUSIONS This case illustrates the challenges faced in the treatment of cerebral tuberculoma, which, in this case, included a high body mass index affecting drug dosage and confounding an inadequate treatment response as seen on interim MRI, resulting in prolonged duration of anti-tuberculosis treatment. Persistent enhancement seen on brain MRI does not equate to treatment failure.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
The American journal of case reports - 22(2021) vom: 10. Juli, Seite e932852 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wong, Qi Ying [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 13.07.2021 Date Revised 28.07.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.12659/AJCR.932852 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM327903333 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM327903333 | ||
003 | DE-627 | ||
005 | 20231225201817.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.12659/AJCR.932852 |2 doi | |
028 | 5 | 2 | |a pubmed24n1092.xml |
035 | |a (DE-627)NLM327903333 | ||
035 | |a (NLM)34244464 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wong, Qi Ying |e verfasserin |4 aut | |
245 | 1 | 0 | |a Diagnostic and Treatment Challenges in Cerebral Tuberculoma in a Patient with Morbid Obesity |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.07.2021 | ||
500 | |a Date Revised 28.07.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND Tuberculosis is prevalent, especially in low-income countries. The most devastating manifestation of tuberculosis is central nervous system (CNS) involvement, albeit rare. CASE REPORT We report a rare case of a 26-year-old woman with morbid obesity and hepatitis C who had cerebral tuberculoma and was treated with an extended duration of anti-tuberculosis multi-drug therapy. This patient was initially diagnosed with disseminated tuberculosis of the lungs, liver, and peritoneum. After 4 months of anti-tuberculosis treatment, she developed new right temporal hemianopia and new cerebral tuberculoma, which was identified on repeated magnetic resonance imaging (MRI) and was attributed to tuberculosis-immune reconstitution inflammatory syndrome. The anti-tuberculosis treatment was continued; however, she gained large amounts of weight, which resulted in the failure of the anti-tuberculosis treatment of the cerebral tuberculoma. We decided to adjust the anti-tuberculosis drug dosage using her total body weight, and she responded well, with a decrease in size of the cerebral tuberculoma. The anti-tuberculosis treatment was subsequently stopped after 3 years because of clinical and imaging improvement. CONCLUSIONS This case illustrates the challenges faced in the treatment of cerebral tuberculoma, which, in this case, included a high body mass index affecting drug dosage and confounding an inadequate treatment response as seen on interim MRI, resulting in prolonged duration of anti-tuberculosis treatment. Persistent enhancement seen on brain MRI does not equate to treatment failure | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Antitubercular Agents |2 NLM | |
700 | 1 | |a Tang, Andy Sing Ong |e verfasserin |4 aut | |
700 | 1 | |a Loh, Wei Huei |e verfasserin |4 aut | |
700 | 1 | |a Yong, Xin Min |e verfasserin |4 aut | |
700 | 1 | |a Samuel, Desmond |e verfasserin |4 aut | |
700 | 1 | |a Law, Wan Chung |e verfasserin |4 aut | |
700 | 1 | |a Chua, Hock Hin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The American journal of case reports |d 2009 |g 22(2021) vom: 10. Juli, Seite e932852 |w (DE-627)NLM226518345 |x 1941-5923 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2021 |g day:10 |g month:07 |g pages:e932852 |
856 | 4 | 0 | |u http://dx.doi.org/10.12659/AJCR.932852 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 22 |j 2021 |b 10 |c 07 |h e932852 |